HFG Advisors’s AbbVie ABBV Stock Holding History

HFG Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$748K	Buy	2,974 +481	+19%	+$103K	0.47%	52
2026 Q1	$542K	Buy	2,493 +1,573	+171%	+$349K	0.38%	56
2025 Q4	$210K	Hold	920	–	–	0.15%	103
2025 Q3	$213K	Buy	+920	New	+$187K	0.16%	95
2025 Q2	–	Sell	-1,059	Closed	-$222K	–	98
2025 Q1	$222K	Buy	+1,059	New	+$206K	0.19%	85
2024 Q4	–	Sell	-1,038	Closed	-$205K	–	94
2024 Q3	$205K	Buy	+1,038	New	+$194K	0.18%	95
2022 Q2	–	Sell	-1,494	Closed	-$242K	–	83
2022 Q1	$242K	Hold	1,494	–	–	0.28%	76
2021 Q4	$202K	Buy	+1,494	New	+$176K	0.23%	80

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

HFG Advisors's ABBV Position: Q2 2026 in Review

HFG Advisors increased its AbbVie (ABBV) stake by 19% in Q2 2026, buying an estimated $103K and bringing the position to 2,974 shares worth $748K. The position accounts for 0.47% of the portfolio, ranked #52.

HFG Advisors first reported a position in ABBV in Q4 2021 and has held it in 8 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

HFG Advisors held 2,974 shares of AbbVie worth $748K as of Q2 2026.
HFG Advisors bought 481 AbbVie shares in Q2 2026, an estimated $103K.
AbbVie made up 0.47% of HFG Advisors's portfolio in Q2 2026, its #52 holding.
HFG Advisors first reported a position in AbbVie in Q4 2021 and has held it in 8 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on HFG Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.